Doris Célanie, Stéphanie Scherier, Amandine Maulard, Patricia Pautier, Alexandra Leary, Catherine Genestie, Philippe Morice, Sébastien Gouy
{"title":"II期和III期浆液性交界性卵巢肿瘤患者的生育结果和肿瘤预后。","authors":"Doris Célanie, Stéphanie Scherier, Amandine Maulard, Patricia Pautier, Alexandra Leary, Catherine Genestie, Philippe Morice, Sébastien Gouy","doi":"10.1016/j.ijgc.2025.101636","DOIUrl":null,"url":null,"abstract":"<p><p>This retrospective study aimed to analyze the fertility results and oncologic outcomes of patients with stage II and III serous borderline ovarian tumors after fertility-sparing surgery and to seek future fertility. Among 224 patients with stage II and III serous borderline ovarian tumors treated or referred to our institution, 74 (33%) underwent fertility-sparing surgery. Median time of follow-up was 4.1 years (range; 3.2-7.9); 35 (47%) patients attempted to be pregnant and 21 (60%) had at least 1 pregnancy. Nineteen live-birth pregnancies were observed (9 spontaneously) in 18 patients (all but 1 with non-invasive implants). Seven patients had recurrent disease treated conservatively before pregnancy and 8 recurred after pregnancy (6 recurred as ovarian borderline tumors and 1 as a low-grade serous carcinoma).</p>","PeriodicalId":14097,"journal":{"name":"International Journal of Gynecological Cancer","volume":" ","pages":"101636"},"PeriodicalIF":4.7000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Fertility results and oncologic outcomes in patients with stage II and III serous borderline ovarian tumors.\",\"authors\":\"Doris Célanie, Stéphanie Scherier, Amandine Maulard, Patricia Pautier, Alexandra Leary, Catherine Genestie, Philippe Morice, Sébastien Gouy\",\"doi\":\"10.1016/j.ijgc.2025.101636\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>This retrospective study aimed to analyze the fertility results and oncologic outcomes of patients with stage II and III serous borderline ovarian tumors after fertility-sparing surgery and to seek future fertility. Among 224 patients with stage II and III serous borderline ovarian tumors treated or referred to our institution, 74 (33%) underwent fertility-sparing surgery. Median time of follow-up was 4.1 years (range; 3.2-7.9); 35 (47%) patients attempted to be pregnant and 21 (60%) had at least 1 pregnancy. Nineteen live-birth pregnancies were observed (9 spontaneously) in 18 patients (all but 1 with non-invasive implants). Seven patients had recurrent disease treated conservatively before pregnancy and 8 recurred after pregnancy (6 recurred as ovarian borderline tumors and 1 as a low-grade serous carcinoma).</p>\",\"PeriodicalId\":14097,\"journal\":{\"name\":\"International Journal of Gynecological Cancer\",\"volume\":\" \",\"pages\":\"101636\"},\"PeriodicalIF\":4.7000,\"publicationDate\":\"2025-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Gynecological Cancer\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/j.ijgc.2025.101636\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/17 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q1\",\"JCRName\":\"OBSTETRICS & GYNECOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Gynecological Cancer","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.ijgc.2025.101636","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/17 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
Fertility results and oncologic outcomes in patients with stage II and III serous borderline ovarian tumors.
This retrospective study aimed to analyze the fertility results and oncologic outcomes of patients with stage II and III serous borderline ovarian tumors after fertility-sparing surgery and to seek future fertility. Among 224 patients with stage II and III serous borderline ovarian tumors treated or referred to our institution, 74 (33%) underwent fertility-sparing surgery. Median time of follow-up was 4.1 years (range; 3.2-7.9); 35 (47%) patients attempted to be pregnant and 21 (60%) had at least 1 pregnancy. Nineteen live-birth pregnancies were observed (9 spontaneously) in 18 patients (all but 1 with non-invasive implants). Seven patients had recurrent disease treated conservatively before pregnancy and 8 recurred after pregnancy (6 recurred as ovarian borderline tumors and 1 as a low-grade serous carcinoma).
期刊介绍：
The International Journal of Gynecological Cancer, the official journal of the International Gynecologic Cancer Society and the European Society of Gynaecological Oncology, is the primary educational and informational publication for topics relevant to detection, prevention, diagnosis, and treatment of gynecologic malignancies. IJGC emphasizes a multidisciplinary approach, and includes original research, reviews, and video articles. The audience consists of gynecologists, medical oncologists, radiation oncologists, radiologists, pathologists, and research scientists with a special interest in gynecological oncology.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
